GAM Systematic’s Bio-Rad Laboratories Class A BIO Stock Holding History

GAM Systematic’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$442K	Sell	1,988 -906	-31%	-$204K	0.06%	428
2017 Q2	$655K	Buy	2,894 +2,624	+972%	+$572K	0.09%	366
2017 Q1	$54K	Buy	+270	New	+$52K	0.01%	559
2016 Q4	–	Sell	-5,078	Closed	-$832K	–	610
2016 Q3	$832K	Buy	5,078 +3,778	+291%	+$573K	0.17%	243
2016 Q2	$186K	Buy	1,300 +544	+72%	+$77.6K	0.04%	505
2016 Q1	$103K	Sell	756 -3,013	-80%	-$396K	0.03%	518
2015 Q4	$523K	Sell	3,769 -2,038	-35%	-$282K	0.15%	281
2015 Q3	$780K	Buy	+5,807	New	+$836K	0.18%	234

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

GAM Systematic's BIO Position: Q3 2017 in Review

GAM Systematic reduced its Bio-Rad Laboratories Class A (BIO) stake by 31% in Q3 2017, selling an estimated $204K and leaving 1,988 shares worth $442K. The position accounts for 0.06% of the portfolio, ranked #428.

GAM Systematic first reported a position in BIO in Q3 2015 and has held it in 8 quarters since. The position peaked at $832K in Q3 2016. 271 funds tracked by Wall St. Rank hold BIO as of Q3 2017.

GAM Systematic held 1,988 shares of Bio-Rad Laboratories Class A worth $442K as of Q3 2017.
GAM Systematic sold 906 Bio-Rad Laboratories Class A shares in Q3 2017, an estimated $204K.
Bio-Rad Laboratories Class A made up 0.06% of GAM Systematic's portfolio in Q3 2017, its #428 holding.
GAM Systematic first reported a position in Bio-Rad Laboratories Class A in Q3 2015 and has held it in 8 quarters since.
GAM Systematic's Bio-Rad Laboratories Class A position peaked at $832K in Q3 2016.
271 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2017.

Based on GAM Systematic's 13F filing for Q3 2017, filed 14 Nov 2017.